Doug Godshall Takes Helm At Galvanize As $100M Round Fuels Next Phase Of PEF Development

New Funding Underpins US-Focused Clinical And Commercial Expansion

 
• By Shubham Singh
  
The company’s focus remains on advancing Aliya in oncology and RheOx in chronic bronchitis as well as continuing to refine the underlying PEF platform. Picture Credit: Shutterstock

More from Financing

More from Business